Hypercalcemic encephalopathy in a patient with hepatocellular carcinoma.
Cirrhotic patients with hepatocellular carcinoma (HCC) frequently develop hepatic encephalopathy. Metabolic etiology of encephalopathy is less often considered in these patients. Although paraneoplastic hypercalcemia may be associated with several malignant tumors, it has also been described in HCC [1-4], and may cause neurologic disturbances. We present a case of hypercalcemic encephalopathy in a patient with hepatic cirrhosis and underlying HCC in whom first diagnostic was hepatic encephalopathy.
Tudela
Pere
P
Unitat de Curta Estada, Emergency Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
Soldevila
Berta
B
Mòdol
Josep Maria
JM
Domènech
Eugeni
E
D000368:Aged; D001928:Brain Diseases, Metabolic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002118:Calcium / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000175:diagnosis; D003937:Diagnosis, Differential; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005665:Furosemide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D004232:Diuretics; D005938:Glucocorticoids; D005665:Furosemide; D011239:Prednisolone; D002118:Calcium